Dr. Ziyad Al-Aly and his team have continued to conduct research on Long COVID and specifically the outcomes it can have on Kidneys.
Manuscripts:
- High-dimensional characterization of post-acute sequelae of COVID-19
- Mapping the effectiveness and risks of GLP-1 receptor agonists
- Postacute Sequelae of SARS-CoV-2 Infection in the Pre-Delta, Delta, and Omicron Eras
- Long-term outcomes following hospital admission for COVID-19 versus seasonal influenza: a cohort study
- Association of Treatment With Nirmatrelvir and the Risk of Post–COVID-19 Condition
- Molnupiravir and risk of post-acute sequelae of covid-19: cohort study
- Cases, Hospitalization, and Mortality in COVID-19 and Influenza Among Veterans in 2022-2025 Influenza Seasons
- Risk of Death in Patients Hospitalized for COVID-19 vs Seasonal Influenza in Fall-Winter 2022-2023
- Mortality in Patients Hospitalized for COVID-19 vs Influenza in Fall-Winter 2023-2024
- Rates of Hospitalization and Death due to COVID-19 in US Veterans With SARS-CoV-2 Infection in the XBB-, JN.1-, and KP-Predominant Eras
- Adverse cardiovascular and kidney outcomes in people with SARS-CoV-2 treated with SGLT2 inhibitors
- Mapping the effectiveness and risks of GLP-1 receptor agonists
- Glucagon-like peptide 1 receptor agonist discontinuation and risks of major adverse cardiovascular events in adults with type 2 diabetes: target trial emulation
- Glucagon-like peptide-1 receptor agonists and risk of substance use disorders among US veterans with type 2 diabetes: cohort study
News Media:
Dr. Jay McDonald has had several articles published on his work on TIDOS.
Dr. Eric Knoche‘s work on Blue Earth was published in a manuscript. Dr. Osman and Dr. Sanfilippo are also listed as authors.
One of our studies, PREVENTABLE, with Dr. Jiafu Ou and study coordinator Marie White was awarded for being the 2nd highest enrollment out of 74 active sites.
Rachael Beard’s study, ‘Move the Needle‘ focuses on the Transitional Care Model. There have been several presentations and publications discussing the benefit of the TCM
- Challenges And Strategies To Implementing The Transitional Care Model: Lessons Learned From The MIRROR-TCM Trial
- Measuring Implementation Fidelity Of The Transitional Care Model In The MIRROR-TCM Trial
- Identifying Care Transitions Needs Experienced By Older Adults and Caregivers Hospital To Home
- MIRROR-TCM Trial: The Influence Of Patient-Level Factors On Acute Care Resource Use of Older Adults
- Lessons from the implementation of the transitional care model during the COVID-19 pandemic
- Challenges and strategies to maintain fidelity to the MIRROR-TCM intervention during the COVID-19 pandemic
Dr. Mohammed Zayed has had his work on several different projects published amongst many different platforms. Links to follow.
Dr. Martin Schoen has 4 published papers and 1 opinion article in the last 2 years that have come from his seed grant and DoD grant. He is also featured on the ORD website for his work on the study ‘AMPLITUDE‘.
- Veterans help find new cancer treatments
- Survival of veterans treated with enzalutamide and abiraterone for metastatic castrate resistant prostate cancer based on comorbid diseases
- Frailty and survival among veterans treated with abiraterone or enzalutamide for metastatic castration-resistant prostate cancer
- Hospitalizations Among Veterans Treated for Metastatic Prostate Cancer With Abiraterone or Enzalutamide
- Effect of BMI and hemoglobin A1c on survival of veterans with metastatic castration-resistant prostate cancer treated with abiraterone or enzalutamide
- Risk of Recurrence After Radiation in Early Prostate Cancer—Role of Risk Stratification From Prospective Trials
Dr. Dhruv Mitroo recently had a paper published for his work with Dr. Ravi. This paper focuses on Combustion conditions influence toxicity of flame-generated soot to ocular (ARPE-19) cells.
Dr. Medhat Osman has had several accepted abstracts in national and international conferences that were published in meeting’s abstract books. Recent examples include imaging meetings such as annual and mid-winter Society of Nuclear Medicine and Molecular Imaging (SNMMI) and Annual European Society of Nuclear Medicine and Molecular Imaging (EANMMI) as well as oncology meetings such as American Society of Clinical Oncology (ASCO).
Dr. Osman also has two manuscripts from my VA work currently under review. (one from the Blue Earth trial and the other is from the SPLASH trial). He is an author on a published manuscript on Blue Earth.
Other Publishings:
- National Medicine Communications
- Oncology PRO
- AMIIC 2023 Annual Meeting (Prague, Czech Republic, Sep 2023)
- SNMMI 2023 Annual Meeting (Chicago, IL, June 2023)
- Analysis of Occupational Exposure Distribution in a Nuclear Medicine Department Beginning Lutetium 177 Therapy Administration
- Anxiety Survey for Standard of Care PET/CT patients with and without Music Therapy: Preliminary Analysis
- Nuclear Medicine Technologists Survey to Assess Workplace Burnout
- Oligometastatic Prostate Cancer as detected with PSMA PET/CT; Impact on Treatment Strategies
- 18F-PSMA PET/CT is Helpful in the Evaluation of Intermediate Risk Favorable and Low Risk Prostate Cancer Patients: A Pictorial Essay
- Calcium score acquisition using the CT of the SPECT scan; added value to myocardial perfusion imaging
- SNMMI 2022